Consolidation radiotherapy for patients with extended disease small cell lung cancer in a single tertiary institution: impact of dose and perspectives in the era of immunotherapy Cover

.blurhash-client-img { display: none !important; }

Consolidation radiotherapy for patients with extended disease small cell lung cancer in a single tertiary institution: impact of dose and perspectives in the era of immunotherapy

Radiology and Oncology

Volume 54 (2020): Issue 3 (September 2020)

By: Karmen Stanic, Martina Vrankar and Jasna But-Hadzic

Open Access

|Jul 2020

Authors

Karmen Stanic

Department of Radiotherapy, Institute of Oncology Ljubljana, Ljubljana, Slovenia

Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia

Martina Vrankar

Department of Radiotherapy, Institute of Oncology Ljubljana, Ljubljana, Slovenia

Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia

Jasna But-Hadzic

Department of Radiotherapy, Institute of Oncology Ljubljana, Ljubljana, Slovenia

Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia

DOI: https://doi.org/10.2478/raon-2020-0046 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099

Journal RSS Feed

Language: English

Page range: 353 - 363

Submitted on: Mar 9, 2020

|

Accepted on: Jul 4, 2020

|

Published on: Jul 29, 2020

Published by: Association of Radiology and Oncology

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

small cell lung cancer,

consolidation radiotherapy,

Related subjects:

Clinical medicine,

Internal medicine,

Haematology, oncology,

© 2020 Karmen Stanic, Martina Vrankar, Jasna But-Hadzic, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous article Volume 54 (2020): Issue 3 (September 2020)Next article